⌘K

Login Start Free

Home/Filings/4/0001104659-21-075263

4//SEC Filing

Lefenfeld Michael 4

Accession 0001104659-21-075263

CIK 0001472012other

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 8:04 PM ET

Size

5.2 KB

Accession

0001104659-21-075263

Insider Transaction Report

Form 4

Period: 2021-05-28

Immunome Inc.IMNM

Lefenfeld Michael

Director

Transactions

Award
Stock Option (Right to Buy)
2021-05-28+3,750→ 3,750 total
Exercise: $20.92Exp: 2031-05-28→ Common Stock (3,750 underlying)

Footnotes (1)

[F1]The shares subject to the option shall vest 25% every quarter after the grant date.

Documents

1 file

4
tm2118079-4_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Immunome Inc.

CIK 0001472012

Entity typeother

Related Parties

1

filerCIK 0001826906

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 8:04 PM ET
Size: 5.2 KB

View on SEC.gov